Clinical Trial Update: Atazavanir/Ritonavir-based HAART in Children [Phase 2]

View source ↗

Summary

This entry notes the completion of a Phase 2 trial evaluating a ritonavir-boosted atazanavir-based HAART regimen in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atazavanir (Atazanavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV | Phase 2 | Status: COMPLETED